Cancer pain pill may also fight opioid addiction risk
NCT ID NCT06200181
Summary
This study is testing if a medication called olanzapine can help reduce cravings for opioid painkillers in cancer patients. It will involve 87 adults with cancer pain who are already taking opioids and are showing signs of potential misuse. Participants will be randomly assigned to receive either olanzapine or a placebo (inactive pill) to see which one better controls cravings and misuse behaviors.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MISUSE, OPIOID are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
MD Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.